McGeer

HEALTH RESEARCH FOUNDATION ANNOUNCES RECIPIENT OF ITS MEDAL OF HONOUR

Retrieved on: 
Wednesday, November 16, 2022
Human, World Health Organization, World, HRF, MERS, Ebola, University, Immunization, Department, Code, Education, Research, Mount Sinai Hospital, Association, McGeer, Patient, COVID-19, Policy, Medal of Honor, Infection, Vaccine, Public policy, Medical laboratory, SARS, Medical device, Medicine, Pharmaceutical industry, Indspire

OTTAWA, ON, Nov. 15, 2022 /CNW/ - The Health Research Foundation (HRF) of Innovative Medicines Canada is pleased to announce that Dr. Allison McGeer is the recipient of its distinguished Medal of Honour.

Key Points: 
  • OTTAWA, ON, Nov. 15, 2022 /CNW/ - The Health Research Foundation (HRF) of Innovative Medicines Canada is pleased to announce that Dr. Allison McGeer is the recipient of its distinguished Medal of Honour.
  • "The Health Research Foundation is extremely proud to present Dr. McGeer with its Medal of Honour.
  • "The HRF has been a longstanding pillar in the health research community and it's an honour to receive this recognition."
  • The Health Research Foundation (HRF) of Innovative Medicines Canada is a non-profit organization that invests in Canadian academic health research and promotes the value of research-driven health innovation in Canada.

Julian Pavone Guinness World Record® Holder is Back Co-Producing New R&B Hit

Retrieved on: 
Friday, May 14, 2021
Given names, Pavone, Annalisa, Julian, McGeer

"Much like her prodigy brother, who is a genius in the studio, Annalisa adapted to the creative process instantly.

Key Points: 
  • "Much like her prodigy brother, who is a genius in the studio, Annalisa adapted to the creative process instantly.
  • "\nAce has worked with some of the world\'s greatest musical legends, including Aretha Franklin, Anita Baker, Aliyah, and currently Annalisa Pavone.
  • McGeer utilized Julian\'s artistic input and vision for this brand.\nAnnalisa Pavone is an exceptional vocalist who is involved with her older brother Julian performing and songwriting.
  • The legacy continues to succeed with his son Bobby Becker.\n"Secret Love" is available on all major music streaming services.\nFor more information on Julian Pavone, visit: julianpavone.com\n'

First Participants Dosed in Appili Therapeutics’ Phase 2 Clinical Trial Evaluating Favipiravir for COVID-19 Outbreak Control in Canadian Long-Term Care Homes

Retrieved on: 
Tuesday, October 20, 2020
Infectious diseases, Biotechnology, Health, Clinical trials, Chemistry, Physical sciences, Allison McGeer, COVID-19 Immunity Task Force, Ebola, Clinical research, Chemical compounds, Favipiravir, Randomized controlled trial, Lunenfeld-Tanenbaum Research Institute, McGeer

Appili is sponsoring the Phase 2 cluster-randomized placebo-controlled trial (cluster-RCT) evaluating the effectiveness of favipiravir as a preventative measure against COVID-19 outbreaks in long-term care (LTC) facilities.

Key Points: 
  • Appili is sponsoring the Phase 2 cluster-randomized placebo-controlled trial (cluster-RCT) evaluating the effectiveness of favipiravir as a preventative measure against COVID-19 outbreaks in long-term care (LTC) facilities.
  • Dr. Allison McGeer , senior clinician scientist at Sinai Healths Lunenfeld-Tanenbaum Research Institute (LTRI) in Toronto, is the studys primary investigator.
  • The study population will include elderly subjects with co-morbidities and front-line healthcare workers with recent COVID-19 exposure or confirmed infection.
  • Dosing the first cluster of participants in our COVID-19 trial is an important milestone for Appilis program.